# Cardiac phenotype in hereditary transthyretin amyloidosis: correlations between fibril types and 99mTc-DPD uptake

**Authors:** Viktor Löfbacka, Jonas Wixner, Per Westermark, Justina Damjanovic Vesterlund, Intissar Anan, Björn Pilebro

PMC · DOI: 10.1038/s41598-026-43816-x · Scientific Reports · 2026-03-16

## TL;DR

This study explores how different types of amyloid fibrils in a genetic disease affect heart symptoms and imaging results in patients from Sweden.

## Contribution

The study identifies distinct clinical and imaging correlations between two amyloid fibril types in hereditary transthyretin amyloidosis.

## Key findings

- Type A fibrils correlate with older age at diagnosis and more severe cardiac involvement.
- A subset of type B fibril patients showed cardiac tracer uptake similar to type A patients.
- 99mTc-DPD scintigraphy results correlate better with clinical phenotype than abdominal fat biopsy findings.

## Abstract

Variant transthyretin amyloidosis is a systemic disease. In Sweden, the Val30Met variant is the most prevalent. Val30Met presents in two phenotypes: an early-onset form dominated by polyneuropathy and a late-onset form frequently accompanied by cardiomyopathy. These phenotypes are associated with two amyloid fibril types. Type A fibrils, contain both fragmented and full-length transthyretin, whereas type B fibrils contain only full-length transthyretin. Fibril type has been linked to differences in cardiac tracer uptake on 99mTc-DPD scintigraphy. A total of 152 patients with confirmed variant transthyretin amyloidosis evaluated at Umeå University Hospital, Sweden, were included. Age at disease onset and cardiac involvement, investigated by echocardiography, Troponin-T, and NT-proBNP, were assessed in relation to fibril type in abdominal fat and scintigraphic findings. Eighty-five patients had type A fibrils and sixty-seven had type B fibrils. Type A patients were older at diagnosis and had pathologic scintigraphies and more severe cardiac involvement. A subset of type B patients (15%) exhibited cardiac tracer uptake and had cardiac characteristics and age at disease onset similar to those with type A fibrils. Even though there was a strong correlation with findings in abdominal fat pad biopsies, results from 99mTc-DPD scintigraphy correlated better with clinical phenotype.

## Linked entities

- **Chemicals:** 99mTc-DPD (PubChem CID 172866590)
- **Diseases:** polyneuropathy (MONDO:0001824), cardiomyopathy (MONDO:0004994)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** TTR (transthyretin) [NCBI Gene 7276] {aka AMYLD1, ATTR, CTS, CTS1, HEL111, HsT2651}
- **Diseases:** amyloid cardiomyopathies (MESH:D009202), conduction disturbances (MESH:C563984), Toxic (MESH:D064420), cardiac involvement (MESH:D006331), ATTRv amyloidosis (MESH:D000686), type B (MESH:D006509), systemic disease (MESH:D034721), Chronic Kidney Disease (MESH:D051436), arrhythmias (MESH:D001145), polyneuropathy (MESH:D011115), heart failure (MESH:D006333), Amyloid (MESH:C000718787), hypertension (MESH:D006973), ATTR amyloidosis (MESH:D028226), restrictive cardiomyopathy (MESH:D002313), Fibril (MESH:D014693), ATTR-CM (MESH:C567782)
- **Chemicals:** Pittsburgh compound B (MESH:C475519), DPD (MESH:C036020), 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (-), 99mTc (MESH:D013667), creatinine (MESH:D003404)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** Phe64Leu, Thr60Ala, Ala45Ser, Glu89Lys, p. Tyr134Cys, Ala45Gly, Ala97Ser, Phe33Leu, His88Arg, Val122Ile, p. Val50Met, Glu54Leu

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12996490/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12996490/full.md

---
Source: https://tomesphere.com/paper/PMC12996490